Jesus Duque-Afonso (J Duque-Afonso, Jesús Duque-Afonso)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Topics

Acute Lymphoblastic Leukemia

Transforming Growth Factor

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Bone marrow transplantation

NPJ precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Ali Farrokhi, Tanmaya Atre, Samuel Salitra, Maryam Aletaha, Ana Citlali Márquez, Matthew Gynn, Mario Fidanza, Sumin Jo, Nina Rolf, Karen Simmons, Jesus Duque-Afonso, Michael L Cleary, Alix E Seif, Tobias R Kollmann, Soren Gantt, Gregor S D Reid
Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia. Blood 144 (8) (2024)
Julia C Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Ulrike Philipp, Sabine Bleul, Thomas Pauli, Julia Falkenstein, Henriette Bertemes, Stepan Cysar, Maria Elena Hess, Anna Verena Frey, Jesus Duque-Afonso, Elisabeth Schorb, Marcia Machein, Jürgen Beck, Oliver Schnell, Nikolas von Bubnoff, Anna L Illert, Christoph Peters, Tilman Brummer, Marco Prinz, Cornelius Miething, Heiko Becker, Silke Lassmann, Martin Werner, Melanie Börries, Justus Duyster, Dieter H Heiland, Roman Sankowski, Florian Scherer
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors. NPJ precision oncology 8 (1) (2024)
Julia C Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Ulrike Philipp, Sabine Bleul, Thomas Pauli, Julia Falkenstein, Henriette Bertemes, Stepan Cysar, Maria Elena Hess, Anna Verena Frey, Jesus Duque-Afonso, Elisabeth Schorb, Marcia Machein, Jürgen Beck, Oliver Schnell, Nikolas von Bubnoff, Anna L Illert, Christoph Peters, Tilman Brummer, Marco Prinz, Cornelius Miething, Heiko Becker, Silke Lassmann, Martin Werner, Melanie Börries, Justus Duyster, Dieter H Heiland, Roman Sankowski, Florian Scherer
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors. NPJ precision oncology 8 (1) (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Tim Strüßmann, J Heinz, Ralph Wäsch, J Jung, Monika Engelhardt, J Duyster, J Finke, Jesus Duque-Afonso, R Marks
Long-term complete remissions of refractory severe idiopathic immune thrombocytopenia treated with daratumumab: A case series. British journal of haematology (2024)
Gaia Gentile, Teresa Poggio, Antonella Catalano, Minna Voutilainen, Mari Lahnalampi, Marta Andrade-Martinez, Tobias Ma, Roman Sankowski, Lina Goncharenko, Stefan Tholen, Kyuho Han, David W Morgens, Marco Prinz, Michael Lübbert, Sophia Engel, Tanja Nicole Hartmann, Gunnar Cario, Martin Schrappe, Lennart Lenk, Martin Stanulla, Justus Duyster, Peter Bronsert, Michael C Bassik, Michael L Cleary, Oliver Schilling, Merja Heinäniemi, Jesus Duque-Afonso
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL. Blood advances 8 (11) (2024)
Jesus Duque-Afonso, Pia Veratti, Usama-Ur Rehman, Heike Herzog, Jan Mitschke, Gabriele Greve, Julian Eble, Bettina Berberich, Johanna Thomas, Milena Pantic, Miguel Waterhouse, Gaia Gentile, Olaf Heidenreich, Cornelius Miething, Michael Lübbert
Identification of epigenetic modifiers essential for growth and survival of AML1/ETO-positive leukemia. International journal of cancer (2024)
Julia C Kuehn, Patrick Metzger, Nicolas Neidert, Uta Matysiak, Linda Gräßel, Ulrike Philipp, Sabine Bleul, Thomas Pauli, Julia Falkenstein, Henriette Bertemes, Stepan Cysar, Maria Elena Hess, Anna Verena Frey, Jesus Duque-Afonso, Elisabeth Schorb, Marcia Machein, Jürgen Beck, Oliver Schnell, Nikolas von Bubnoff, Anna L Illert, Christoph Peters, Tilman Brummer, Marco Prinz, Cornelius Miething, Heiko Becker, Silke Lassmann, Martin Werner, Melanie Börries, Justus Duyster, Dieter H Heiland, Roman Sankowski, Florian Scherer
Comprehensive genetic profiling and molecularly guided treatment for patients with primary CNS tumors. NPJ precision oncology 8 (1) (2024)
Ali Farrokhi, Tanmaya Atre, Samuel Salitra, Maryam Aletaha, Ana Citlali Márquez, Matthew Gynn, Mario Fidanza, Sumin Jo, Nina Rolf, Karen Simmons, Jesus Duque-Afonso, Michael L Cleary, Alix E Seif, Tobias R Kollmann, Soren Gantt, Gregor S D Reid
Early-life infection depletes preleukemic cells in a mouse model of hyperdiploid B-cell acute lymphoblastic leukemia. Blood (2024)
Tanmaya Atre, Ali Farrokhi, Sumin Jo, Samuel Salitra, Jesus Duque-Afonso, Michael L Cleary, Nina Rolf, Gregor S D Reid
Age and ligand specificity influence the outcome of pathogen engagement on preleukemic and leukemic B-cell precursor populations. Blood advances (2023)
Miriam Mozaffari Jovein, Gabriele Ihorst, Jesus Duque-Afonso, Ralph Wäsch, Hartmut Bertz, Claudia Wehr, Justus Duyster, Robert Zeiser, Juergen Finke, Florian Scherer
Long-term follow-up of patients with acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation after primary induction failure. Blood cancer journal 13 (1) (2023)
Radu-Florian Gherman, Sophie Ewald, Gabriele Ihorst, Tim Strüßmann, Robert Zeiser, Ralph Wäsch, Hartmut Bertz, Daiana Stolz, Justus Duyster, Jürgen Finke, Reinhard Marks, Monika Engelhardt, Jesus Duque-Afonso
Identification of clinical factors impacting outcome in patients undergoing autologous hematopoietic cell transplantation after BEAM and TEAM conditioning. European journal of haematology (2023)
Jesus Duque-Afonso, Juergen Finke, Maud Ngoya, Jacques-Emmanuel Galimard, Charles F Craddock, Kavita Raj, Adrian Bloor, Emma Nicholson, Matthias Eder, Orchard Kim, Thomas Valerius, John A Snowden, Eleni Tholouli, Charles Crawley, Matthew Collin, Keith M O Wilson, Alain Gadisseur, Rachel Protheroe, Eva Maria Wagner-Drouet, Bipin P Savani, Alexandros Spirydonidis, Fabio Ciceri, Arnon Nagler, Florent Malard
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone marrow transplantation (2023)
Gila Mostufi-Zadeh-Haghighi, Pia Veratti, Kyra Zodel, Gabriele Greve, Miguel Waterhouse, Robert Zeiser, Michael L Cleary, Michael Lübbert, Jesus Duque-Afonso
Functional Characterization of Transforming Growth Factor-β Signaling in Dasatinib Resistance and Pre-BCR + Acute Lymphoblastic Leukemia. Cancers 15 (17) (2023)
Linda C Schuster, Afzal P Syed, Stephan M Tirier, Simon Steiger, Isabelle Seufert, Heiko Becker, Jesus Duque-Afonso, Tobias Ma, Seishi Ogawa, Jan-Philipp Mallm, Michael Lübbert, Karsten Rippe
Progenitor like cell type of an MLL-EDC4 fusion in acute myeloid leukemia. Blood advances (2023)
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Florian Scherer, Robert Zeiser, Justus Duyster, Hartmut Bertz, Juergen Finke, Jesus Duque-Afonso
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers 14 (14) (2022)
Patricia K Grüninger, Franziska Uhl, Heike Herzog, Gaia Gentile, Marta Andrade-Martinez, Tobias Schmidt, Kyuho Han, David W Morgens, Michael C Bassik, Michael L Cleary, Oliver Gorka, Robert Zeiser, Olaf Groß, Jesus Duque-Afonso
Functional characterization of the PI3K/AKT/MTOR signaling pathway for targeted therapy in B-precursor acute lymphoblastic leukemia. Cancer gene therapy 29 (11) (2022)
Jesus Duque-Afonso, Jürgen Finke, Myriam Labopin, Charles F Craddock, Rachel Protheroe, Panagiotis Kottaridis, Eleni Tholouli, Jenny L Byrne, Kim Orchard, Urpu Salmenniemi, Inken Hilgendorf, Hannah Hunter, Emma Nicholson, Adrian J C Bloor, John A Snowden, Mareike Verbeek, Andrew Clark, Bipin N Savani, Alexandros Spirydonidis, Arnon Nagler, Florent Malard
Comparison of fludarabine-melphalan and fludarabine-treosulfan as conditioning prior to allogeneic hematopoietic cell transplantation-a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone marrow transplantation 57 (8) (2022)
Marion Subklewe, Jesus Duque-Afonso, Michael Lübbert
AML1/ETO and its function as a regulator of gene transcription via epigenetic mechanisms. Oncogene 40 (38) (2021)
Jesus Duque-Afonso, Sophie Ewald, Gabriele Ihorst, Miguel Waterhouse, Tim Struessmann, Robert Zeiser, Ralph Wäsch, Hartmut Bertz, Joachim Müller-Quernheim, Justus Duyster, Jürgen Finke, Reinhard Marks, Monika Engelhardt
The impact of pulmonary function in patients undergoing autologous stem cell transplantation. Blood advances 5 (21) (2021)
Rieke Schröder, Anna-Lena Illert, Thalia Erbes, Christian Flotho, Michael Lübbert, Jesus Duque-Afonso
The epigenetics of breast cancer - Opportunities for diagnostics, risk stratification and therapy. Epigenetics (2021)
Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess, Meike Reiser, Julius Wehrle, Patrick Metzger, Anna Verena Frey, Heiko Becker, Konrad Aumann, Kai Berner, Martin Boeker, Nico Buettner, Christine Dierks, Jesus Duque-Afonso, Michel Eisenblaetter, Thalia Erbes, Ralph Fritsch, Isabell Xiang Ge, Anna-Lena Geißler, Markus Grabbert, Steffen Heeg, Dieter Henrik Heiland, Simone Hettmer, Gian Kayser, Alexander Keller, Anita Kleiber, Alexandra Kutilina, Leman Mehmed, Frank Meiss, Philipp Poxleitner, Justyna Rawluk, Juri Ruf, Henning Schäfer, Florian Scherer, Khalid Shoumariyeh, Andreas Tzschach, Christoph Peters, Tilman Brummer, Martin Werner, Justus Duyster, Silke Lassmann, Cornelius Miething, Melanie Börries, Anna L Illert, Nikolas von Bubnoff
Transitioning the Molecular Tumor Board from Proof of Concept to Clinical Routine: A German Single-Center Analysis. Cancers 13 (5) (2021)
C Greil, M Engelhardt, Gabriele Ihorst, Jesus Duque-Afonso, K Shoumariyeh, H Bertz, R Marks, Robert Zeiser, J Duyster, J Finke, Ralph Wäsch
Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia. Bone marrow transplantation 56 (4) (2020)
Jesus Duque-Afonso, Gabriele Ihorst, Miguel Waterhouse, Robert Zeiser, Ralph Wäsch, Hartmut Bertz, Mehtap Yücel, Thomas Köhler, Joachim Müller-Quernheim, Reinhard Marks, Jürgen Finke
Comparison of reduced-toxicity conditioning protocols using fludarabine, melphalan combined with thiotepa or carmustine in allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (1) (2020)
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Max Deuter, Nikolas von Bubnoff, Florian Scherer, Tim Strüssmann, Claudia Wehr, Justus Duyster, Hartmut Bertz, Jürgen Finke, Jesus Duque-Afonso
Colon and liver tissue damage detection using methylated SESN3 and PTK2B genes in circulating cell-free DNA in patients with acute graft-versus-host disease. Bone marrow transplantation 56 (2) (2020)
Julius Wehrle, Ulrike Philipp, Martina Jolic, Marie Follo, Saskia Hussung, Silvia Waldeck, Max Deuter, Michael Rassner, Jan Braune, Justyna Rawluk, Christine Greil, Cornelius F Waller, Heiko Becker, Jesus Duque-Afonso, Anna-L Illert, Ralph M Fritsch, Frank Meiss, Justus Duyster, Nikolas von Bubnoff, Florian Scherer
Personalized Treatment Selection and Disease Monitoring Using Circulating Tumor DNA Profiling in Real-World Cancer Patient Management. Diagnostics (Basel, Switzerland) 10 (8) (2020)